EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

Marjanka K Schmidt1, Jennifer E Kelly2, Anne Brédart3

  • 1Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

European Journal of Cancer (Oxford, England : 1990)
|January 15, 2023
PubMed

Related Concept Videos